Covaxin use for children aged between 2-18 years awaited to get DCGI approval

Prameyanews English

Published By : Prameya News Bureau | October 12, 2021 IST

New Delhi, Oct 12: Covaxin is yet to get approval by the Drugs Controller General of India (DCGI) for children between 2-18 years old, according to official sources. The Bharat Biotech has submitted data from clinical trials in the 2-18 years age group for COVAXIN (BBV152) to Central Drugs Standard Control Organisation (CDSCO). The data has been thoroughly reviewed by the CDSCO and Subject Experts Committee (SEC) who have provided their positive recommendations. wp:embed {"url":"https://twitter.com/ANI/status/1447860619252699139","type":"rich","providerNameSlug":"twitter","responsive":true} https://twitter.com/ANI/status/1447860619252699139 /wp:embed

News7 Is Now On WhatsApp Join And Get Latest News Updates Delivered To You Via WhatsApp

You Might Also Like

More From Related News

Copyright © 2024 - Summa Real Media Private Limited. All Rights Reserved.